BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1540945)

  • 1. Antibody dependent cell mediated cytotoxicity on human cervical carcinoma cell line, ME-180, with human monoclonal antibody.
    Osumi K; Nagao J; Yuasa H; Fujimoto H; Hagiwara H; Kodera Y; Ohno R
    Cancer Lett; 1992 Feb; 62(2):179-83. PubMed ID: 1540945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
    Rosales C; Jeglum KA; Obrocka M; Steplewski Z
    Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF; Nieroda C; De Filippi R; Greiner JW; Correale P; Schlom J; Tsang KY
    Immunol Lett; 1995; 47(1-2):15-24. PubMed ID: 8537095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
    Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
    Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
    Beum PV; Lindorfer MA; Taylor RP
    J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
    Poston RN; Morgan RS
    Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Sone S
    Jpn J Cancer Res; 1996 May; 87(5):497-504. PubMed ID: 8641987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Cell Immunol; 1985 Apr; 92(1):105-14. PubMed ID: 4075410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
    Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
    Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity using a murine monoclonal antibody against human colorectal cancer in cancer patients.
    Takamuku K; Akiyoshi T; Tsuji H
    Cancer Immunol Immunother; 1987; 25(2):137-40. PubMed ID: 3664531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage.
    Schneider-Merck T; Lammerts van Bueren JJ; Berger S; Rossen K; van Berkel PH; Derer S; Beyer T; Lohse S; Bleeker WK; Peipp M; Parren PW; van de Winkel JG; Valerius T; Dechant M
    J Immunol; 2010 Jan; 184(1):512-20. PubMed ID: 19949082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions.
    Awwad M; Strome PG; Gilman SC; Axelrod HR
    Cancer Immunol Immunother; 1994 Jan; 38(1):23-30. PubMed ID: 8299115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.